Author: Tousoulis Dimitris Antoniades Charalambos Stefanadis Christodoulos
Publisher: Springer Publishing Company
ISSN: 0031-6970
Source: European Journal of Clinical Pharmacology, Vol.62, Iss.1, 2006-02, pp. : 101-107
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Celecoxib: beneficial effects in coronary artery disease
Inpharma, Vol. 1, Iss. 1374, 2003-01 ,pp. :
Warfarin: Mechanisms for Durable Effects in Coronary Artery Disease
Heart Drug, Vol. 2, Iss. 4, 2002-11 ,pp. :